Both biofilm cytotoxicity and monocytes' adhesion may be used as estimators of enterococcal virulence.
Agnieszka DacaLidia PiechowiczKatarzyna WiśniewskaEwa BrylJacek M WitkowskiTomasz JarzembowskiPublished in: Letters in applied microbiology (2024)
Our study aimed to identify markers of enterococci's virulence potential by evaluating the properties of strains of different sites of isolation. Enterococcal strains were isolated as commensals from faeces and as invasive strains from the urine and blood of patients from the University Clinical Centre, Gdańsk, Poland. Changes in monocytes' susceptibility to the cytotoxic activity of isolates of different origins and their adherence to biofilm were evaluated using a flow cytometer. The bacterial protein profile was estimated by MALDI-TOF MS. The cytotoxicity of biofilm and monocytes' adherence to it were the most accurate factors in predicting the prevalence of the strain in the specific niche. Additionally, a bacterial protein with mass-to-charge ratio (m/z) 5000 was found to be responsible for the increased bacterial cytotoxicity, while monocytes' decreased adherence to biofilm was linked with the presence of proteins either with m/z 3330 or 2435. The results illustrate that monocytes' reaction when exposed to the bacterial biofilm can be used as an estimator of pathogens' virulence potential. The observed differences in monocytes' response are explainable, by the bacterial proteins' profile. Additionally, the results indicate that the features of both bacteria and monocytes impact the outcome of the infection.
Keyphrases
- pseudomonas aeruginosa
- staphylococcus aureus
- biofilm formation
- escherichia coli
- dendritic cells
- candida albicans
- peripheral blood
- cystic fibrosis
- antimicrobial resistance
- end stage renal disease
- methicillin resistant staphylococcus aureus
- newly diagnosed
- type diabetes
- chronic kidney disease
- risk factors
- high resolution
- glycemic control
- insulin resistance
- peritoneal dialysis
- small molecule
- protein protein
- metabolic syndrome
- skeletal muscle
- climate change
- anti inflammatory